VANI vs. FONR, HYPR, ELMD, ECOR, MOVE, POCI, PXDT, SMLR, OM, and AXGN
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include FONAR (FONR), Hyperfine (HYPR), Electromed (ELMD), electroCore (ECOR), Movano (MOVE), Precision Optics (POCI), Pixie Dust Technologies (PXDT), Semler Scientific (SMLR), Outset Medical (OM), and AxoGen (AXGN). These companies are all part of the "electromedical equipment" industry.
Vivani Medical (NASDAQ:VANI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment.
FONAR has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
FONAR received 168 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 73.48% of users gave FONAR an outperform vote.
FONAR has a net margin of 10.66% compared to Vivani Medical's net margin of 0.00%. FONAR's return on equity of 7.50% beat Vivani Medical's return on equity.
In the previous week, Vivani Medical had 2 more articles in the media than FONAR. MarketBeat recorded 2 mentions for Vivani Medical and 0 mentions for FONAR. Vivani Medical's average media sentiment score of 0.68 beat FONAR's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.
Vivani Medical has a beta of 3.26, indicating that its share price is 226% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.
6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 55.6% of Vivani Medical shares are held by company insiders. Comparatively, 2.2% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
FONAR beats Vivani Medical on 9 of the 14 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
